Cardiovascular Market Research Reports & Industry Analysis
Variations in heart size and position within the chest may be related to age, body size, shape, weight, or pathologic conditions of the heart and other nearby structures.
There has been considerable study into the role of inflammation in heart disease. Researchers have found the first direct evidence that reducing inflammation in coronary arteries decreases the risk of heart attacks as much as reducing cholesterol levels. This finding offers a new approach to preventing heart disease. Two studies showed that inflammation of the arteries can be reduced by more aggressive use of statins. New drugs that target inflammation that are measured by a marker called Creactive rotein (CRP) could have a large impact on cardiovascular health as well as a large financial gain for companies developing these products.
Cardiovascular Industry Research & Market Reports
-
Acute Heart failure (AHF) – Market Insight, Epidemiology, and Market Forecast – 2034
... Heart failure (AHF), historical and forecasted epidemiology as well as the Acute Heart failure (AHF) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Acute Heart failure ... Read More
-
Angina (Angina Pectoris) – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Angina (Angina Pectoris) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Angina (Angina Pectoris) market report provides current ... Read More
-
Postmyocardial Infarction Syndrome – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Postmyocardial Infarction Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Postmyocardial Infarction Syndrome market report provides current ... Read More
-
Post-Cardiac Arrest Syndrome (PCAS) – Market Insight, Epidemiology, and Market Forecast – 2034
... Arrest Syndrome (PCAS), historical and forecasted epidemiology as well as the Post-Cardiac Arrest Syndrome (PCAS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Post-Cardiac Arrest Syndrome ... Read More
-
Hypertrophic Cardiomyopathy (HCM) – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Hypertrophic Cardiomyopathy (HCM) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Hypertrophic Cardiomyopathy (HCM) market report provides current ... Read More
-
Cardiac Arrythmia – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Cardiac Arrythmia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Cardiac Arrythmia market report provides current treatment practices, emerging drugs, Cardiac ... Read More
-
Dyslipidemia – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Dyslipidemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Dyslipidemia market report provides current treatment practices, emerging drugs, Dyslipidemia market share of the individual ... Read More
-
Ischemic Stroke – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Ischemic Stroke market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Ischemic Stroke market report provides current treatment practices, emerging drugs, Ischemic ... Read More
-
Heart Failure – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Heart Failure market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Heart Failure market report provides current treatment practices, emerging drugs, Heart ... Read More
-
BNP And NTproBNP Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (BNP (Brain Natriuretic Peptide), NT-proBNP (N-terminal Pro-B-Type Natriuretic Peptide), By Location of Testing (Point Of Care Testing, Laboratory Testing), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Others), By Region and Competition, 2019-2029F
... By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Others), By Region and Competition, 2019-2029F Global BNP And NT-proBNP Market was valued at USD 1840.56 Million in 2023 and is anticipated to project ... Read More
-
North America Cardiac Markers Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Reagents and Kits, and Analyzers), Biomarker Type (Troponin, Creatine Kinase-MB, Myoglobin, B-Type Natriuretic Peptide, and Others), Indication (Congestive Heart Failure, Myocradial Infraction, Acute Coronary Syndrome, and Others), End User (Hospitals, Diagnostic Laboratories, Point-of-Care Testing Facilities, and Others), and Country (US, Canada, Mexico)
... Myoglobin, B-Type Natriuretic Peptide, and Others), Indication (Congestive Heart Failure, Myocradial Infraction, Acute Coronary Syndrome, and Others), End User (Hospitals, Diagnostic Laboratories, Point-of-Care Testing Facilities, and Others), and Country (US, Canada, Mexico) The global North ... Read More
-
RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2033
... By End User: Hospitals; Research Laboratories; Pharmaceutical And Biotechnology CompaniesCovering: Ionis Pharmaceuticals; Alnylam Pharmaceuticals; Sarepta Therapeutics; Jazz Pharmaceuticals; Novartis RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2033 from The Business Research ... Read More
-
Contract Research and Manufacturing Service (CRAMS) Market in India 2024-2028
... 10.8% during the forecast period. The report on the contract research and manufacturing service (CRAMS) market in India provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor ... Read More
-
Global Myocardial Infarction Market Report by Drug Class (Antiplatelet Agents, Glycoprotein IIb/IIIa Inhibitors, Antithrombotic Agents, Beta-adrenergic Blockers, Vasodilators, Angiotensin-converting Enzyme (ACE) Inhibitors, Angiotensin-receptor Blockers, Analgesics, Thrombolytics), Distribution Channels (Hospitals, Hospital Pharmacies, Drug Stores, Online Drug Stores), Regions and Company Analysis 2024-2032
... Stores), Regions and Company Analysis 2024-2032 Global Myocardial Infarction Market share was valued at US$ 2.02 Billion in 2023. It is anticipated to increase at a CAGR of 6.06% from 2024 to 2032 and be ... Read More
-
EPA and DHA Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... USD 2.76 billion by 2029, growing at a CAGR of 7.51% during the forecast period (2024-2029). The market for EPA and DHA is primarily driven by increasing awareness regarding potential health benefits associated with fatty ... Read More
-
2024 Global Forecast for Peripheral Arterial Disease (Pad) Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx ... Read More
-
2024 Global Forecast for Cardiology Information System Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
Global Anticoagulant Reversal Drugs Databank Market Report
... 2023 to 2031. Idarucizumab segment is expected to be the highest contributor to this market, with $288.6 Million in 2022, and is anticipated to reach $799.0 Million by 2031, registering a CAGR of 12.05%. Phytonadione ... Read More
-
Global Acute Coronary Syndrome Therapeutic Databank Market Report
... 4.44% from 2023 to 2031. Non-St-Elevation Myocardial Infarction segment is expected to be the highest contributor to this market, with $3,528.2 Million in 2022, and is anticipated to reach $4,904.8 Million by 2031, registering a ... Read More
-
Global Aortic Aneurysm Databank Market Report
... 2029. Ambulatory Surgery Centers segment is expected to be the highest contributor to this market, with $2,708.4 Million in 2020, and is anticipated to reach $3,655.4 Million by 2029, registering a CAGR of 3.43%. Hospitals ... Read More
-
Global Congestive Heart Failure Treatment Devices Databank Market Report
... CAGR of 6.88% from 2023 to 2031. Implantable Cardioverter Defibrillators segment is expected to be the highest contributor to this market, with $9,692.6 Million in 2022, and is anticipated to reach $16,736.9 Million by 2031, ... Read More
-
Medical Tourism Market Share, Size, Trends, Industry Analysis Report By Treatment Type (Orthopedic Treatment, Cardiovascular Treatment, Neurological Treatment, Cosmetic Treatment, Dentistry Treatment, Other Treatments); By Regions, Segment Forecast, 2020
... market size is expected to reach USD 80.07 billion by 2032, according to a new study by Polaris Market Research. The report “Medical Tourism Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Cosmetic ... Read More
-
Cardiovascular Information System Market Size, Trends, Analysis, and Outlook By Mode of Operation (Web based, Cloud based, On site), By System (CVIS, CPACS), by Country, Segment, and Companies, 2024-2032
... size is poised to register 9.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Cardiovascular Information System market across By Mode of ... Read More
-
Enzyme Inhibitors Market Size, Trends, Analysis, and Outlook By Type (Proton Pump Inhibitors (PPIs), Protease Inhibitors, Reverse Transcriptase Inhibitors, Aromatase Inhibitors, Kinase Inhibitors, Neuraminidase Inhibitors, Statins, Others), By Application (Chemotherapy, Antibiotics, Pesticides, Cardiovascular Treatments, Others), by Country, Segment, and Companies, 2024-2032
... by Country, Segment, and Companies, 2024-2032 The global Enzyme Inhibitors market size is poised to register 4.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Homocysteine Testing Market Size, Trends, Analysis, and Outlook By Type (Folic Acid, Pyridoxine, Cobalamin), By Form (Tablet, Syrup, Others), By Distribution Channel (Hospital Pharmacies, Drug Stores, Others), by Country, Segment, and Companies, 2024-2032
... Homocysteine Testing market size is poised to register 7.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Homocysteine Testing market across By ... Read More
Research Assistance
